Assistant Professor, Medicine, Georgetown University School of Medicine
Hematology
Dr. Aiwu R. He, MD
|
|
Give Review
Aiwu R. He, MD practices Hematology. She studied medicine at Hunan Medical University. Aiwu is a published doctor. She has 21 publications published. The most current publication "Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer." She is registered with Medicare and accepts Medicare payments.
Publications
- Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic Cancer.
- Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma.
- A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor Malignancies.
- Transcriptional regulation of STAT3 by SPTBN1 and SMAD3 in HCC through cAMP-response element-binding proteins ATF3 and CREB2.
- Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer.
- βII-spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and wnt signaling via regulation of wnt inhibitor kallistatin.
- Treating hepatocellular carcinoma progression following first-line sorafenib: therapeutic options and clinical observations.
- A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor Malignancies.
- Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases.
- Liver Cancer stem cells.
- Current problems with systemic treatment of advanced hepatocellular Cancer.
- Evaluation of hypertension as a marker of bevacizumab efficacy.
- Liver stem cells and hepatocellular carcinoma.
- Progenitor/stem cells give rise to liver Cancer due to aberrant TGF-beta and IL-6 signaling.
- Acute venous disease: venous thrombosis and venous trauma.
- Biologic therapy for colon Cancer.
- Stem cells in gastrointestinal Cancers.
- Biologic therapies for advanced pancreatic Cancer.
- Clinical experiences with G17DT in gastrointestinal Malignancies.
- Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic Cancer.
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
Hunan Medical University
Hospital
-
MedStar Georgetown University Hospital
Drug Facts
| NPI NUMBER | 1942306360 | |
| NPPES Provider LastName | HE | |
| NPPES Provider FirstName | AIWU | |
| NPPES Provider ZIPCode | 200072113 | |
| NPPES Provider State | DC | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 167.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942306360 |
| Last Name Of The Provider | HE |
| First Name Of The Provider | AIWU |
| View All |
Similar Doctors
|
|
Dr. Stephen Liu, MD |
|
|
Dr. Theresa M. Lee, MD |
|
|
Dr. Jane M. Ingham, MD |
|
|
Dr. Laleh Amiri-Kordestani, MD |
|
|
Dr. Louis M. Weiner, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jamie L. Koprivnikar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ekatherine Asatiani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Henry B. Fox, MD |
|
|
Dr. Katherine Thornton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brandon G. Smaglo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig M. Kessler, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. George K. Philips, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce D. Cheson, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|